Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Endomagnetics Strengthens its Operations: Makes Two Key Appointments

Abstract:
Endomagnetics, the company developing advanced magnetic sensing technology for use in cancer staging, has announced two key appointments as it expands in its new Cambridge base. Dr Andrew Shawcross has been appointed Director Operations and Dr Quentin Harmer is the new Director Technology. Both appointments are with immediate effect.

Endomagnetics Strengthens its Operations: Makes Two Key Appointments

Cambridge, UK | Posted on November 22nd, 2011

Dr Shawcross brings over twenty years of experience in operational and project management and will help grow the operational capabilities of Endomagnetics and support its manufacturers and supply chain. Dr Shawcross has held senior positions at ICI, Zeneca, Avecia and latterly at Cambridge Display Technology (CDT) where he was Business Development Manager.

Dr Harmer brings more than a decade of experience in medical devices and will help develop Endomagnetics' technical and regulatory capabilities. Dr Harmer joins from Vectura Group plc where he was Project Director on dry powder inhaler products, and was previously responsible for the development of the Aspirair dry powder inhaler technology at Cambridge Consultants.

Both Shawcross and Harmer bring a strong combination of deep technical background with commercial experience in developing and delivering technology to the market. They join Endomagnetics at an important time as the company prepares to launch its SentiMag® system with its magnetic tracer, Sienna+™, on the European market.

"I am delighted to welcome both Andrew and Quentin in these important new roles at Endomagnetics", said Dr Eric Mayes, Chief Executive Officer. "We are entering an exciting phase as we accelerate the market introduction of the technology, and their combined skills significantly expand the capabilities of the management team."

Magnetic sensing for cancer staging has the potential to replace the current standard of care of using radioactive isotopes. Radioisotopes limit the availability of the current best practice SLNB technique to around half of eligible patients in the West, and a much smaller proportion in Asia.

####

About Endomagnetics
Endomagnetics solves cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.

The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for detecting a magnetic tracer called Sienna+™ to help identify critical lymph nodes in support of cancer staging. Cambridge-based Endomagnetics is in the process of delivering its technology to global markets.

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695
E-mail:

Company contact:
Dr Eric Mayes
CEO
Endomagnetics Ltd
Tel: +44 (0)1223 437131
E-mail:

Copyright © Endomagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Nanomedicine

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Announcements

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Appointments/Promotions/New hires/Resignations/Deaths

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

Industry Veteran Fergus Clarke Joins Picodeon as CEO: Appointment comes as Picodeon prepares for growth April 8th, 2014

Peter B. Littlewood appointed Director of Argonne National Laboratory March 26th, 2014

Global 450 consortium announces new general manager of internal operations: TSMC’s Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE